About KuartisMED
KuartisMED is a company based in Ankara (Turkey) founded in 2012 by Aylin Tarcan, Ahmet Saracoglu, and Ayse Nur Ecevit. KuartisMED has raised $1.8 million across 6 funding rounds from investors including European Union, Arya Women and APY Ventures. KuartisMED offers products and services including NeoSAFE, Nimie, and stetsafe. KuartisMED operates in a competitive market with competitors including Elvie, Owlet, Press Ganey, Willow and Feedtrail, among others.
- Headquarter Ankara, Turkey
- Founders Aylin Tarcan, Ahmet Saracoglu, Ayse Nur Ecevit
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.8 M (USD)
in 6 rounds
-
Latest Funding Round
$1.8 M (USD), Seed
Nov 28, 2022
-
Investors
European Union
& 7 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of KuartisMED
KuartisMED offers a comprehensive portfolio of products and services, including NeoSAFE, Nimie, and stetsafe.
Device for safe feeding and monitoring of newborns.
Provides precision care solutions for baby health.
Tool for fast and effective newborn hygiene maintenance.
People of KuartisMED
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of KuartisMED
KuartisMED has successfully raised a total of $1.8M across 6 strategic funding rounds. The most recent funding activity was a Seed round of $1.8 million completed in November 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in KuartisMED
KuartisMED has secured backing from 8 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include European Union, Arya Women and APY Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Sector-agnostic startups are accelerated by Arya Women in Turkey.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Growth Circuit is engaged in supporting and funding startups.
|
Locked | Locked | Locked |
Investor details for KuartisMED
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by KuartisMED
Investment portfolio details for KuartisMED
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - KuartisMED
Detailed financials for KuartisMED
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Kuartismed Comparisons
Peer comparison for KuartisMED
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of KuartisMED
KuartisMED operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Elvie, Owlet, Press Ganey, Willow and Feedtrail, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Internet first brand offering wearable breast pumps
|
|
| Locked | Locked | Locked |
Owlet is recognized for developing FDA-cleared smart baby monitors.
|
|
| Locked | Locked | Locked |
Software for patient satisfaction surveys is provided to healthcare organizations.
|
|
| Locked | Locked | Locked |
Wearable double electric breast pump kits and accessories are provided.
|
|
| Locked | Locked | Locked |
Feedback management platform for healthcare professionals
|
|
| Locked | Locked | Locked |
Connected care platform capturing health data of children health for professionals
|
Detailed competitors of KuartisMED
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Kuartismed
Complete news archive for KuartisMED
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about KuartisMED
KuartisMED was founded in 2012 and raised its 1st funding round 2 years after it was founded.
KuartisMED is headquartered in Ankara, Turkey. It is registered at Ankara, Ankara, Turkey.
Ahmet Saracoglu is the current CEO of KuartisMED. They have also founded this company.
KuartisMED is a funded company, having raised a total of $1.8M across 6 funding rounds to date.
Developer of a device to assess the feeding maturity of preterm babies. The companys devices include Neosafe which is a non-invasive biomedical diagnostic device for monitoring the feeding ability of newborns.
KuartisMED's top competitors include Elvie, Owlet and Press Ganey.
KuartisMED offers NeoSAFE, Nimie, and stetsafe.
KuartisMED has 8 investors. Key investors include European Union, Arya Women, APY Ventures, Growth Circuit, and Techmine Solutions.